Issar Pharmaceuticals
Issar Pharmaceuticals is a privately held medical drug development company founded in 1995 and headquartered in Hyderabad, India, employing 101–250 staff. It operates within India's pharmaceutical R&D sector, though its specific pipeline, therapeutic focus, and commercial activities are not publicly disclosed.
- Company typePrivate
- Founded1995
- HeadquartersHyderabad, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Issar Pharmaceuticals does
Issar Pharmaceuticals is a privately held medical drug development company founded in 1995, headquartered in Hyderabad, India. It operates with a workforce of 101–250 employees and is positioned within India's pharmaceutical R&D ecosystem in Hyderabad — a major hub for drug discovery, formulation development, and contract research. The company is for-profit, not publicly listed, and maintains a web presence at issar.co.in.
The substantive business profile of Issar Pharmaceuticals — including its specific therapeutic areas, drug pipeline candidates, development stage, technology platform, regulatory filings, intellectual property, and commercialization strategy — is not disclosed in the available source material. The primary corporate website returned only a loading/verification placeholder rather than substantive content, and no product details, leadership team, partnerships, certifications, or financial statements were available in the input data. The sole quantified capital event on record is a $3.83M funding round in February 2019, with investors undisclosed.
As a result, this analysis is necessarily constrained by a thin evidence base. What can be stated with reasonable confidence is limited to the firmographic footprint: an Indian pharma R&D entity of mid-small scale (101–250 staff), privately held, founded nearly three decades ago, with limited recent public capital formation activity visible in the supplied data. Investors evaluating Issar should treat the absence of pipeline, leadership, and financial disclosure as a material due diligence gap.
Issar Pharmaceuticals firmographics
Firmographics- Name
- Issar Pharmaceuticals
- Legal name
- Issar Pharmaceuticals
- Website
- https://issar.co.in
- Company type
- Private
- Founded year
- 1995
- Headcount range
- 101–250 employees
- Short description
- Issar Pharmaceuticals is a privately held medical drug development company founded in 1995 and headquartered in Hyderabad, India, employing 101–250 staff. It operates within India's pharmaceutical R&D sector, though its specific pipeline, therapeutic focus, and commercial activities are not publicly disclosed.
- Ownership category
- akta.pro rank
Issar Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Drug Development
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)
Keywords
Where Issar Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Markets served
Issar Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations
Issar Pharmaceuticals product offering
Product offeringCore offering
Issar Pharmaceuticals is a medical drug development company engaged in pharmaceutical research and the creation of drug formulations. Headquartered in Hyderabad, India, and founded in 1995, the company operates in the pharmaceutical sector with 101–250 employees.
Differentiator
Problem solved
Functional benefit
Companies that use Issar Pharmaceuticals
Customer profileIdeal customer profiles1 record
Issar Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Issar Pharmaceuticals partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Issar Pharmaceuticals competitors and assessment
Company assessmentBroad incumbents
- Cipla Limited: Major Indian pharmaceutical company with a broad drug development and formulations business including CNS products, providing a comparable broad-incumbent reference point in the same geography as Issar.
- Pfizer: Global pharmaceutical major with extensive CNS and neurology product franchises, comparable to Issar as a broad incumbent reference in the same therapeutic categories at global scale.
- Sun Pharmaceutical Industries: India's largest pharmaceutical company with a broad CNS and specialty product portfolio, comparable to Issar as a broad incumbent in Indian pharma with overlapping therapeutic categories and substantially greater scale.
- Zydus Lifesciences (Cadila): Large India-based pharmaceutical group with CNS and neurology products, broad formulations portfolio, and active drug development programs; comparable to Issar as a broad incumbent in the same geography and overlapping therapeutic areas.
- Lupin Limited: One of India's largest pharmaceutical companies with a broad CNS and formulations portfolio; a broad incumbent peer operating in the same therapeutic areas and Indian market as Issar, but at materially larger scale.
- Eli Lilly: Global pharmaceutical major with a leading CNS portfolio including depression and migraine therapies, providing a broad incumbent reference point for the CNS therapeutic areas that Issar targets.
Regional players
- Glenmark Pharmaceuticals: India-headquartered pharmaceutical company with a specialty and CNS franchise including migraine and neurology products, comparable to Issar as a regional player in overlapping therapeutic categories.
- Natco Pharma: India-based mid-cap pharmaceutical company with drug development programs across CNS and specialty indications, comparable to Issar in geographic positioning and mid-sized stage profile.
- Torrent Pharmaceuticals: India-headquartered mid-cap pharmaceutical company with a CNS product portfolio and operations across formulations and generics, comparable to Issar as an India-based peer with overlapping therapeutic categories and similar scale tier.
Direct peers
- Suven Life Sciences: India-based pharmaceutical company historically focused on CNS drug development including depression, dementia, and migraine indications, making it the closest direct peer to Issar in therapeutic focus, geography, and stage profile.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Issar Pharmaceuticals social profiles
Digital presenceIssar Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Issar Pharmaceuticals leadership team
Management profileNumber of profiles
Issar Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Issar Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Issar Pharmaceuticals
What does Issar Pharmaceuticals do?
Issar Pharmaceuticals is a medical drug development company engaged in pharmaceutical research and the creation of drug formulations. Headquartered in Hyderabad, India, and founded in 1995, the company operates in the pharmaceutical sector with 101–250 employees.
When was Issar Pharmaceuticals founded?
Issar Pharmaceuticals was founded in 1995. It employs 101 to 250 people.
Where is Issar Pharmaceuticals based?
Issar Pharmaceuticals is headquartered in Hyderabad, India, in the Asia region.
Who are Issar Pharmaceuticals's main competitors?
Broad incumbents on record are Cipla Limited, Pfizer, Sun Pharmaceutical Industries, Zydus Lifesciences (Cadila), Lupin Limited and Eli Lilly. Regional players are Glenmark Pharmaceuticals, Natco Pharma and Torrent Pharmaceuticals. Suven Life Sciences is listed as a direct peer.
Does Issar Pharmaceuticals have an API?
No public API is recorded for Issar Pharmaceuticals.
What industry is Issar Pharmaceuticals in?
Issar Pharmaceuticals's product category is Pharmaceutical Drug Development. Its primary akta.pro industry code is HLAIAAAF, Neurology & Psychiatry (CNS) Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.